Infant reflux and regurgitation can be a burden for the family as well as the healthcare system
Causes
Reflux and regurgitation are considered normal physiological processes that occur several times a day in healthy infants. They are caused by the valve at the top of the stomach having a weak action allowing food and stomach acid to move back into the oesophagus.1 Regurgitation is the most common infant feeding problem affecting almost 1 in 3 infants.2
Rome IV Diagnostic Criteria3
Must include both of the following, in otherwise healthy infants, 3 weeks to 12 months of age:
- Regurgitation 2+ times per day for 3+ weeks
- Without the presence of retching, hematemesis, aspiration, apnoea, failure to thrive, feeding or swallowing difficulties, or abnormal posturing
Research indicates that reflux reaches its peak around 4 months and begins to resolve by 7 months although some infants may have symptoms up to 12 months.1,3 Every infant will vary in this.
ESPGHAN Guidelines on Management4
EAACI Review of Pharmacological Management5
- No guideline recommends the use of prokinetic agents
- ESPGHAN4 found insufficient evidence to recommend a trial with an alginate
- H2RAs do not reduce crying/distress or visible regurgitation/vomiting and have limited evidence on efficacy and safety
- Concerns that PPIs impact the long-term bioavailability of certain vitamins/minerals and increase the risk of developing food allergy
IMPORTANT NOTICE
Breastfeeding is best. Foods for special medical purposes should only be used under medical supervision. May be suitable for use as the sole source of nutrition for infants from different ages, and/or as part of a balanced diet from 6 months onwards. Refer to label for details.
- Vandenplas et al. J Pediatr Gastroenterol Nutr 2009; 49:498–547.
- Vandenplas et al. J Pediatr Gastroenterol Nutr 2015;61:531–7
- Benninga MA et al. Gastroenterology 2016; 150: 1443–1455.e2.
- Rosen R et al. J Pediatr Gastroenterol Nutr 2018; 66(3):516– 554
- Meyer R et al., Pediatr Allergy Immunol. 2022 Oct;33(10):e13856. doi: 10.1111/pai.13856. PMID: 36282131
ESPGHAN: European Society of Paediatric Gastroenterology Hepatology and Nutrition; GERD: Gastroesophageal Reflux Disease; GI: Gastrointestinal; EAACI: European Academy of Allergy & Clinical Immunology; H2RA: Histamine 2-Receptor Antagonists; PPI: Proton Pump Inhibitors